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Abstract 
 
The formation of well-ordered nanostructures through self-assembly of diverse organic and 
inorganic building blocks has drawn much attention owing to their potential applications in biology 
and chemistry. Among all organic building blocks, peptides are one of the most promising 
platforms due to their biocompatibility, chemical diversity, and resemblance with proteins. 
Inspired from the protein assembly in biological systems, various self-assembled peptide structures 
have been constructed using several amino acids and sequences. This review focuses on this 
emerging area, the recent advances in peptide self-assembly, and formation of different 
nanostructures, such as tubular, fibers, vesicles, spherical, and rod coil structures. While different 
peptide nanostructures are discovered, potential applications will be explored in drug delivery, 
tissue engineering, wound healing, and surfactants. 
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1. Introduction 
Nanometer-sized structures have attracted major attention owing to their potential for 
diverse applications ranging from nanotechnology to biotechnology. In biological systems, 
proteins, DNA, cellular organelles, and microorganisms are submicron sized objects. Thus, they 
can be considered as ‘biological nanostructures’ when compared to synthetic nanostructures.  
Self-assembly is a spontaneous process of organization of chaotic molecular units into 
ordered structures as a result of intramolecular/intermolecular interactions.1 The process of 
assembly is controlled by the balance of attractive/repulsive forces within and between molecules. 
The generation of many biological nanostructures occurs through the self-assembly process, such 
as DNA double helix formation through hydrogen bonding interactions between nucleotide bases, 
protein’s tertiary or quaternary structure through folding of a polypeptide chain, and the formation 
of cell membranes upon self-assembly of phospholipids. The most straightforward and extensively 
known self-assembled structure in a biological system is the lipid membrane structure. The cell 
membrane consists of lipid bilayers that are arranged in such a way that their hydrocarbon tails 
face one another to make a hydrophobic bilayer while their hydrophilic head groups are exposed 
to aqueous solutions on each side of the membrane.  
The self-assembly process is mediated through noncovalent interactions including van der 
Waals, electrostatic, hydrogen bonding, and stacking interactions. The fabrication of new materials 
using natural building blocks, such as phospholipids, oligosaccharides, oligonucleotides, proteins, 
and peptides, has become a subject of major interest.2 Among them, peptides have drawn 
significant attention due to their simple structure, relative chemical and physical stability, diversity 
in sequences and shapes, and feasibility to synthesize in large amounts. In addition, peptides have 
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become known as immensely useful building blocks for creating self-assembled nanostructures in 
medical applications due to their intrinsic biocompatibility and biodegradability.  
Proteins and peptides are made up of 20 natural L-amino acids. All of the natural amino 
acids are chiral in nature except glycine and contain carboxylic acid and amino groups. The only 
difference in their structure is in the side chain groups attached to the chiral carbon. Amino acids 
as building blocks of peptides have various physicochemical properties, because of variety in 
charge, hydrophobicity, size, and polarity in side chains. The number, type, and sequence of amino 
acids can be manipulated to design self-assembled peptides. Depending upon the amino acid 
sequence, the peptide can form different structures. Many human medical disorders are associated 
with polypeptide self-assembly into amyloid fibrils.3  
The versatility of the peptides, in conjunction with their ability to form specific secondary 
structures, provides a unique platform for the design of nanomaterials with controllable structural 
features. A number of peptide-based building blocks, such as cyclic peptides, amphiphilic 
peptides, copolypeptides, surfactant-like oligopeptides, dendritic peptides, and aromatic 
dipeptides, have been designed and developed for generating supramolecular structures and the 
exploration of their possible applications in biology and nanotechnology. Key advantages of self-
assembled peptides relative to conventional structures include biocompatibility, biodegradability, 
and versatility.   
Self-assembled peptide nanostructures have demonstrated considerable potential as 
biomaterials4 and use for carrier-mediated drug delivery, tissue engineering, antimicrobial agents, 
imaging tools, energy storage, biomineralization, and membrane protein stabilization.5 Thus, the 
self-assembly properties of peptides have been exploited for generating bio-inspired 
nanostructures, including nanotubes, nanofibers, nanospheres, nanobelts, and hydrogels.6  
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Herein, we review representative examples and highlights of peptide nanostructures, such 
as tubular, fibers, ribbons, vesicles, spherical structures, and rod coil structures. A comprehensive 
review of all self-assembled peptide nanostructures is beyond the scope of this manuscript. We 
apologize that many excellent works were not included here. Table 1 summarizes the sequences 
of the peptides and the corresponding formed nanostructures discussed in this review. 
 
2. Peptide Nanostructures 
2.1. Tubular Nanostructures 
Nanotubes are nanometer size tube-like structures. They are elongated nanostructures 
which have definite inner hole. Nanotubes are particularly attractive because of their potential 
applications in biology, chemistry, and physics, such as chemotherapy, drug delivery, catalysis, 
molecular separation, optics, and electronics.7 Over the past few decades, researchers have made 
significant progress in covalently bonded nanostructures. Currently, noncovalent nanotubes have 
become subjects of major interest due to their significant advantages including facile synthesis, 
self-organization, control in diameter size, and high efficiency. A number of protocols have been 
reported for the preparation of the noncovalently self-assembled nanotubes using different 
structures including hollow bundles of rod-like units, helical structures, and stacked rings. It is 
generally known that the simplest peptide block for the self-assembly is diphenylalanine peptide 
(L-Phe-L-Phe, FF),8 which forms a tubular structure with a long persistence length (~ 100 µm). 
The self-assembly is mediated through hydrogen bonding as well as π–π stacking of aromatic 
residues. Other tubular structures include cyclic peptide and peptide amphiphile nanotubes. 
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2.1.1. Cyclic Peptide Nanotubes 
The self-assembled cyclic peptide nanotubes formed by stacking of peptides and 
stabilization by hydrogen bonds have attracted major interest because of the ease to change their 
structural and functional properties. For this kind of self-assembly, peptides can adopt particular 
orientation, where amino acid side chains are directed toward outward whiled the carbonyl and the 
amino groups of the peptide backbone are directed perpendicular to the ring and participate in 
intermolecular hydrogen bonding.  
The pioneer work on cyclic peptide nanotubular structures was carried out by Ghadiri and 
co-workers.9a They demonstrated a new class of organic nanotubes based on rationally designed 
of heterochiral cyclic peptides. These peptides formed extended β-sheet-like structures, and 
stacked on top of each other to form hollow and extended cylinders.9 The peptide nanotubes were 
formed using the sequence: cyclo[(D-Ala-Glu-D-Ala-Gln)2]. The investigators used alternating D- 
and L-amino acids in making the cyclic heterochiral octapeptide that generated a planar ring and 
self-assembled through hydrogen bonding to form nanotube structures with a specific diameter. 
The self-assembly was triggered in acidic environment and generated nanotube structures through 
hydrogen bond interactions of ring-shaped peptides subunits. They hypothesized that cyclic 
peptide having an even number of alternating D-and L-amino acids could adopt a low-energy ring 
shaped flat conformation. All backbone peptide amide groups became orientated perpendicular to 
the plane of the structure and participate in backbone-backbone intermolecular hydrogen bonding 
to generate an adjacent antiparallel β-sheet structure (Figure 1). Thus, controlled acidification of 
alkaline peptide solution triggered the spontaneous self-assembly of peptide subunits into rod-
shaped crystals, which was an organized collection of hundreds of tightly packed nanotubes. 
Intersubunit hydrogen bonding provided the main driving force in the assembly process. In 
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contrast, ring stacking is not favorable at alkaline pH, due to the repulsive intermolecular 
interactions between the negatively charged carboxylate side chains of glutamate. The internal 
diameter of the nanotubes ranged between 7-8 Å and was controlled by changing the number of 
amino acids in the peptide sequence.10  
 
Figure 1. Cyclic peptide structures with alternating D- and L-amino acids adopted flat ring-shaped 
conformations and assembled into ordered parallel arrays of solid-state nanotubes. The illustration 
emphasizes the antiparallel ring stacking and the presence of extensive hydrogen-bonding 
interactions between subunits (for clarity most side chains are omitted). Reprinted with permission 
from ref. 10. Copyright 2013 American Chemical Society.  
 
Various applications of these peptide nanotubes have been explored in diverse fields. The 
structural features of these cyclic peptides were very unique. When they were placed in such a 
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condition that formed hydrogen bonding, for example, adsorption onto lipid membranes, they 
stacked to form hollow, β-sheet like tubular structures. The authors suggested that rationally 
designed cyclic D,L-α-peptides could potentially self-assemble in bacterial membranes and exhibit 
antibacterial activity by increasing the membrane permeability.11 These cyclic peptides decorated 
with suitable hydrophobic surface residues formed transmembrane channel structures by 
spontaneous self-assembly on inclusion of an ample concentration of the peptide monomer in lipid 
bilayers. They further suggested that not only the hydrophobic nature of the channel-forming 
peptide was a major factor, but also the peptide played a part in extended hydrogen-bonded 
stacking interactions to construct long channel structures to wrap the lipid bilayer. Ghadiri et al 
proposed that the transmembrane channel structures with larger pore diameters could have 
potential application in molecular transport across lipid bilayers and can be used as a delivery tool 
into living cells in antisense and gene therapy applications.9b  
Another cyclic peptide that was reported to self-assemble into tubular structures was the 
Lanreotide octapeptide, which was synthesized as a growth hormone inhibitor.12 Lanreotide was 
shown to self-assemble into nanotubes of viral capsid-like dimension. The nanotube walls were 
composed of helical filaments that were formed by self-assembly of peptide dimer building blocks 
to antiparallel β-sheets through an alternating pattern of the aromatic amino acid and aliphatic 
residues. 
 
2.1.2. Peptide Amphiphile (PA) Nanotubes 
Some nanotubular structures were also formed by self-assembly of peptide amphiphiles 
(PAs).13 PAs represent a simple category of the designed self-assembling peptides bearing the lipid 
or surfactant characteristics. They possess a hydrophobic tail and a hydrophilic head. The tails of 
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PAs are normally composed of nonpolar amino acid residues (G, A, V, I, L, P and F). The tails 
also can be made of hydrocarbon chains or combination of the hydrocarbon chain and nonpolar 
amino acids. Positively charged amino acids (H, K, and R) and/or negatively charged residues (D 
and E) have been found as appropriate to be used in heads. Glycine rich amphiphilic peptide GnD2–
OH (where n= 4, 6, 8, 10) generated nanotubular structures with two dimensions, one with 40-80 
nm and another in the order of 100-200 nm.14 Molecular modeling studies revealed that peptides 
formed bilayer structures to confiscate the glycine chains from the aqueous system. Nevertheless, 
unlike lipids, peptides formed hydrogen bonds with one another on the backbone. The glycines 
were filled inside of the bilayer away from water and the aspartic acids were exposed to water, 
similar to other surfactants (Figure 2). 
 
Figure 2. Molecular modeling of cut-away structures formed from the peptides with negatively 
charged heads and glycine tail. Left picture shows peptide nanotube with an area sliced away. 
Right picture exhibits a peptide nanovesicle. Color code: red, negatively charged aspartic acid 
heads; green, nonpolar glycine tail. The modeled dimension is 50-100 nm in diameter. Reprinted 
with permission from ref. 14. Copyright 2013 American Chemical Society.  
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Interestingly, peptides containing alanine and valine tails have been found to form more 
stable structures than those of glycine, isoleucine, and leucine. Peptides containing valine, Ac-
V6D-OH formed nanotube as well as nanovesicles.  Tubular structures  were found in self-
assembly of other PAs, such as trifluoroacetate salt of A6K and I3K (Ac-I3K-NH2).
15a The diameter 
of nanotube formed by A6K peptide was found to be 25-30 nm, whereas the diameter of nanotubes 
formed by shorter peptide, I3K was about 10 nm and lengths over 5 µm. The formation of 
nanostructures from the short peptide clearly indicates that the balances between the peptide 
sequence and the size of hydrophobic residues controls the amphiphilicity of a peptide. Then, FTIR 
and solid sate NMR (SSNMR) spectroscopy was used to elucidate the molecular architecture of 
the peptide nanotube formed by A6K.
15b Qualitative information from FTIR indicated that 
antiparallel β-strands aligned perpendicular to the nanotube axis. SSNMR technique revealed the 
tilt angle of the peptide hydrogen bonding axis within the nanotube framework. This class of 
peptide surfactant exhibited properties similar to those of common surfactants, such as n-dodecyl-
β-D-maltoside (DM) and octyl-D-glucoside (OG). The potential applications of these peptides 
were investigated by using A6D as a model peptide surfactant in the stabilization of membrane 
protein, such as G protein-coupled receptor bovine rhodopsin.15c A6D not only showed efficiency 
in stabilizing the membrane protein in the presence of lipid and other common surfactants, but also 
it can be used as stabilizer alone under thermal denaturation conditions without any common 
surfactants.  
Sometimes molecular geometry also affects the formation of nanostructures. For example, 
cone-shaped PA, Ac-GAVILRR-NH2, which has a hydrophobic tail with increasing 
hydrophobicity and a large cationic head group composed of two arginine residues led to the 
formation of the simultaneous shapes of nanosphere and nano-doughnut structures (Figure 3).16 
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The outer and inner diameters of the doughnut-shaped structures were around 110 nm and 25 nm, 
respectively. Self-assembly pathway leading to the pattern of doughnut-shaped nanostructures was 
probably through fusion or elongation of short spherical micelles that merged side by side to form 
that nanostructures.17  
 
 
Figure 3. Proposed plausible self-assembly process of the nanodoghnut structure. (A) Randomly 
oriented and distributed peptides at low concentration; (B) Micelle formation above the critical 
aggregation concentration (CAC); (C) Fusion or elongation of the micelles for the formation of a 
nanopipe; (D) Bending of the nanopipe for the formation of a nanodoughnut structure. Reprinted 
with permission from ref. 16. Copyright 2013 American Chemical Society.  
 
Cone-shaped peptide amphiphiles Ac-A2V2L3WE2/7–OH that were produced 
recombinantly from the bacterial culture,18 formed nano-vesicles with radius size around 60 nm. 
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Self-assembly of this peptide started at pH 5.0. This pH triggered self-assembly could be 
particularly useful in drug delivery applications.  
Effect of molecular structure was found in the self-assembly of the series of PAs, such as 
AmK (where m = 3, 6 and 9). These peptides showed different shapes and size with increasing 
hydrophobic tail length. A3K peptide aggregated at higher concentration compared to A6K and 
A9K, probably due to its weak hydrophobicity. A3K formed unstable peptide sheet stacks. In 
contrast, A6K formed long nanotubes while A9K self-assembled into short nanorods (Figure 
4).19,20a  
 
Figure 4. Schematic illustration of peptide surfactant self-assembly. (a) A3K had the shortest chain 
and had no apparent critical aggregation concentration (CAC) detected, giving rise to the lowest 
effective ae (equilibrium area occupied by each surfactant at the curved interface in the aggregate) 
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and the highest packing parameter; consequently, stacked A3K bilayers were formed. (b) With 
increasing hydrophobic tail length and decreasing CAC of A6K, the electrostatic repulsion between 
the head groups increased. This, together with the packing and entropic effect, led to the lowering 
of the packing parameter and the formation of nanofibers. (c) A9K had the lowest CAC, the highest 
electrostatic repulsion between head groups, and the largest entropic effect arising from the longest 
tail, resulting in the lowest p and the formation of nanorods. In each case, lysine (K) groups 
remained at the outer surface of the nanostructures formed. Reprinted with permission from ref. 
19. Copyright 2013 American Chemical Society.  
 
The nanofibers formed by A6K had the uniform diameter of 8 nm with quite flexible in 
nature. Transmission Electron Microscopy (TEM) image of A9K showed the formation of thin and 
short nanorods with a diameter of 3 nm and length of 100 nm. The trend is consistent with packing 
theory extensively used for common surfactants.   
A dialkyl tail containing PA was developed by Matthew et al.20b to design micelles as 
antigen delivery vehicles in vivo. Two palmityl chains (C16) was conjugated to a peptide containing 
a cytotoxic T-cell epitope derived from ovalbumin. The peptide sequence was termed as OVA 
(EQLESIINFEKLTWE). DiC16-OVA amphiphiles self-assembled into cylindrical micelles.  
 
2.2. Nanofibers 
Nanofibers are defined as fibers with a diameter size of less than 100 nanometer. Basically, 
the difference between nanofibers and nanotubes is that nanotubes are hollow structures. Herein, 
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we discuss the nanofibers formed by PAs and peptides with alternating hydrophobic and 
hydrophilic amino acids 
 
2.2.1. PAs as Nanofibers 
This category of structures is mostly generated by PAs, which consist of hydrophobic alkyl 
tails and hydrophobic heads, similar to lipids. Phospholipid membrane in the biological systems 
also composes of a hydrophilic head and a hydrophobic tail. PAs self-assemble into ordered 
structures in water through hydrophobic interactions. PAs have the structural features of both 
amphiphilic surfactants and functions of bioactive peptides. These molecules generally assemble 
in water into nanofibers at specific solution conditions (temperature, pH, and ionic strength). 
Furthermore, it has been demonstrated that stable nanofibers can be formed by mixing two 
oppositely charged PA molecules to support favorable ionic interactions.21  
A broad class of amphiphilic molecules has been used to create organized biomaterials by 
Stupp and co-workers. For example, an artificial 3D scaffold consisting of nanofiber networks was 
formed by the aggregation of the amphiphilic molecule IKVAV. This process was triggered by the 
addition of neural progenitor cell suspensions to the aqueous solution.22 The investigators used the 
3D network of nanofiber scaffold to encapsulate cells in vitro which promoted very rapid 
differentiation of cells into neurons.  
To investigate the nature of the interiors of self-assembled cylindrical aggregates, Stupp 
and coworkers explored fluorescence techniques using fluorophores, such as tryptophan or pyrene, 
in the peptide backbone.23  PAs bearing fluorophores (tryptophan or pyrene) when self-assembled 
at low pH and exhibited differing degrees of exposure to the solvent and accessibility to the 
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quencher. Interior of tryptophan bearing amphiphiles nanostructures remained well solvated 
irrespective of the positions of fluorophore, suggesting easy access of hydrophilic molecules inside 
the aggregates. Stern-Volmer quenching analysis, a method for quantifying the degree of solvent 
exposure of a protein, indicated different degrees of quencher (pyrene) infiltration into the 
nanostructures.  
Stupp and his group also designed a series of PAs to make one dimensional cylindrical 
nanostructures. PAs containing hydrophobic alkyl chains self-assemble into nanofiber structures 
because of hydrophobic collapse and β-sheet formation.24 Upon pH changes, these PAs formed 
aqueous gels. The stability of these materials can be increased by reversible polymerization. Their 
one dimensional fiber structures were restricted when theses PAs were mixed with dumbbell-
shaped template containing hydrophobic oligo (p-phenylene ethynylene) core.25 Atomic Force 
Microscope (AFM) and TEM data revealed a significant change in the PA supramolecular 
aggregation from nanofibers to small monodisperse nanostructures upon the addition of the 
dumbbell shape scaffold.25  
Self-assembly of PAs into nanofibers was also triggered by light as shown by Stupp and 
his group.27a A photoacid generator (PAG) was introduced to lower the pH upon exposure to light 
to promote the self-assembly of the pH-responsive PAs inside liposomes. Encapsulation of PAs 
within the aqueous interior of liposomes was carried out by using a PA solution to hydrate a 
phospholipid film. The light-triggered PA self-assembly and encapsulation were confirmed by 
confocal fluorescent microscopy, Scanning Electron Microscopy (SEM), Fourier Transform 
Infrared Spectroscopy (FTIR), and circular dichroism (CD). The investigators proposed that 
packed nanofibers within the interior of liposomes could have potential application in targeting 
specific tissues or tumors.  
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Self-assembly of amphiphilic oligopeptide consisting of arginine headgroups into fibril 
structures was investigated by Hamley et al.27b Alanine-rich peptide A12R2 containing twelve 
alanine residues and two arginine residues was synthesized via N-carboxyanhydride (NCA)-
polymerization method. Self-assembly was driven by the electrostatic repulsion between the 
arginine headgroups, leading to the formation of twisted fibril and stacking of alanine residues.  
Castelletto et al explored the possibility of self-assembly of a bioactive dipeptide L-
Carnosine (βAH, where A = alanine, H = histidine) by incorporating a bulky aromatic 
substituent.27c Fmoc [(N-(fluorenyl-9-methoxycarbonyl)], commonly used as protecting agent in 
solid-phase peptide synthesis has been used as structure-directing agent to induce fibrillization of 
carnosine. Fibrillization of carnosine occurred via π-π stacking interaction. They also 
demonstrated that this Fmoc-peptide retained the chelating property with Zn2+ ions even after 
fibrillization. They further extended their work by incorporating a lipid chain with L-carnosine to 
investigate the self-assembly of βAH.   
C16 palmitoyl lipid chain has been used as structure-directing agent to induce the 
fibrillization of βAH.27d PA hexadecyl-(β-alanine-histidine) (C16-βAH) self-assembled into 
nanotape structures due to the hydrophobicity and excluded volume constraints imposed by the 
lipid tail. The investigators further demonstrated that the addition of C16-βAH to DPPC 
(dipalmitoyl phosphatidylcholine) multilamellar vesicles led to the formation of well-defined 
unilamellar vesicles.   
The self-assembly behavior of commercially available PA, matrixyl consists of palmitoyl 
(C16) hydrophobic chain and peptide KTTKS was investigated by Valeria et al.
27e C16-KTTKS was 
incorporated into antiwrinkle skin care creams with the trade name of Matrixyl. This compound 
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self-assembled in a relatively dilute solution. The acetate salt of this PA formed a giant fibrillar 
structures with several micrometer length. Investigation at the nanoscale revealed extended tape 
structures with a persistent length extending to ten of microns or more. Small angle X-ray 
scattering (SAXS) indicated a bilayer structures within the tape. In contrast, the TFA salt of peptide 
amphiphile C16-KTTKS exhibited temperature-dependent self-assembly behaviour. 
27f At higher 
temperature, it formed micelles instead of nanotape structures. At low temperature, β-sheet 
nanotape was stabilized by hydrogen bonding whereas hydrogen bonding was disrupted at higher 
temperature. Self-assembly of C16-KTTKS was fine-tuned by adjusting the pH of the solution.
27g 
As the pH decreased from 7 to 4, a transition in morphology occurred from tape to twisted fibrils. 
Again it formed tape like structures at lower pH (pH 3). In contrast, spherical micelles were 
observed at pH 2. Nanotape structures were also found when C16-KTTKS was mixed with C16-
ETTES.27h Electrostatic interactions between anionic residue E (glutamic acid) and cationic 
residue K (lysine) led to the formation of fibrillar self-assembled structures. 
Self-assembly of tryptophan containing PA C16-W3K exhibited transition in morphology 
from spherical micelles to worm like micelles.27i Initially, it showed discrete spherical micelles 
structures of diameter about 10 nm. In contrast, after 13 days it exhibited long nanofibrillar 
structures with outer diameter of approximately 10 nm. It was hypothesized that the transition was 
probably due to the peptide configurational transition. The CD results indicated that the secondary 
structure of the molecule changed from mixture of α-helix and random coil to β-sheet with time 
without any external stimuli. 
PAs also self-assembled into nanostructures in presence of macromolecules.  The cationic 
Lys-PA self-assembled (C12-VVAGK-Am) into nanofiber in presence of Bcl-2 antisense 
oligonucleotide (ODN) through electrostatic interaction.27j This conjugate was investigated for the 
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slow release of ODN from the nanofiber network. Moreover, it delivered the antisense 
oligonucleotide efficiently inside the cells in controlled way, which resulted the down regulation 
of Bcl-2 mRNA levels, indicating the potential use of PA in gene targeted therapy.  
Self-assembly of bacteria-derived lipopeptides was investigated by Hamley et al.27k The 
lipopeptides surfactin, plipastatin, and mycosubtilin consisting of cyclic peptide head groups and 
different alkyl chains were obtained from Bacillus subtilis. Surfactin and plipastatin self-
assembled into spherical micelles whereas mycosubtilin formed extended nanotape structures. The 
distinct mode of self-assembly of mycosubtilin compared to the other two peptides was attributed 
due to the differences in the surfactant packing parameters.  
Polymer containing PAs have been designed and the bioactivity of the self-assembled 
structures has been investigated by Valeria et al.27l Peptide DGRFFF containing the RGD cell 
adhesion motif was conjugated with poly(ethylene glycol) (PEG) chain of molar mass 3000 kg 
mol-1. At high concentration the polymer-peptide conjugate formed nanofibril structures despite 
the presence of crystallization of PEG, which occurs during drying process, indicating the strong 
tendency of aggregation of the conjugate. Cell proliferation was observed in presence of the 
conjugate at optimum concentration. 
Incorporation of titanium-based biomaterials in the existing tissues is one of the key 
problems in the area of orthopaedic and dental implants. To address this biocompatibility issue, 
Hakan et al demonstrated the biofunctionalization of titanium by immobilizing a bone ECM-
mimetic self-assembled peptide nanofiber on the metal surface.27m To accomplish this, two PAs 
were designed. In one sequence, PA molecule (Lauryl-VVAGE) was covalently conjugated to 
Dopa (3,4-dihydroxy-L-phenylalanine) which showed strong binding with hydrophilic surface. 
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Another PA molecule (Lauryl-VVAG) was conjugated to a heparin binding adhesion peptide 
sequence, KRSR. These conjugated molecules Lauryl-VVAGE-Dopa-Am (Dopa-PA) and Lauryl-
KRSR-Am (KRSR-PA) exhibited self-assembled nanofiber structures driven by electrostatic 
interaction at the physiological pH via β-sheet formation. 
A PA molecule incorporating photocleavable groups between hydrophobic and peptide 
domains were designed by Muraoka et al.28 This PA molecule consisted of a 2-nitrobenzyl group, 
a palmitoyl tail, and an oligopeptide segment GV3A3E3. The 2-nitrobenzyl group was covalently 
linked to the N-terminal amide of the glycine residue and was cleaved by irradiation at 350 nm 
(Figure 5). This PA molecule containing the photocleavable group self-assembled into quadruple 
helical fibers, which was converted to a nonhelical fibril upon irradiation. 
 
Figure 5. Cleavage of 3-nitrobenzyl group from a PA molecule consisting of a 2-nitrobenzyl 
group, a palmitoyl tail, and an oligopeptide segment GV3A3E3. Reprinted with permission from 
ref. 28. Copyright 2013 American Chemical Society.  
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2.2.2. β-Sheet Peptides with Alternating Hydrophobic and Hydrophilic Amino Acids as 
Nanofibers 
The β-sheet structure, along with the α-helix, is one of the major secondary structural 
elements in proteins. The polypeptide chains remain as extended β-sheet structure. The nearby β-
strands can lie in either a parallel or an antiparallel fashion. In both fashions,  the orientation of the 
β-strands become such a way that alternate amino acid side chains remain towards the opposite 
sides of the sheet. Sometimes, the electrostatic and hydrophobic forces among the amino acid side 
chains stabilize the sheets.  
Peptides containing alternating hydrophilic and hydrophobic amino acid residues are 
known to have a strong tendency to generate β-sheet structures.26,29  Alkylated peptide amphiphiles 
consisting of hydrophobic and negatively charged residues (V and E) and an alkyl chain with 16 
carbons (C16H31OVEVE) self-assembled into flat 1D giant nanobelt structures.
26   The structural 
template of VEVE flips the hydrophilic and hydrophobic side chains to the opposite sides of the 
peptide amide backbone when adopting an extended β-strand conformation. It was hypothesized 
that hydrophobic valine residue had a tendency to form a dimer to avoid exposure to water. 
Tapping-mode AFM imaging revealed the flat, belt like morphology of the nanostructures formed 
in aqueous solution over the course of 2 weeks. The investigators assumed that the alternating 
sequence of amino acids led to more effective chain packing within the peptide region and 
formation of the nanobelt morphology (Figure 6).  
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Figure 6. Nanobelts assembled from a PA containing four amino acids and an alkyl tail. (a) 
Chemical structure of the PA. (b-d) AFM images of peptide nanobelts at different scanning sizes. 
The assembled nanobelts are the dominant structures in the assembly system (almost artifact free). 
Reprinted with permission from ref. 26. Copyright 2013 American Chemical Society.  
 
Interestingly, replacing the VEVE peptide segment with a structural motif of VVEE having 
different sequence of amino acids residues led to the formation of cylindrical nanofibers under 
similar conditions (Figure 7).  On the other hand, when alternating sequence of VEVE was 
replaced with VVEE, the cylindrical curvature was regained back as shown in Figure 7. 
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Figure 7. Cryo-TEM image of 0.1 wt % C16H31OVVEE aqueous solution clearly demonstrates 
cylindrical nanofibers. Reprinted with permission from ref. 26. Copyright 2013 American 
Chemical Society.  
 
Short peptide KFE8 (FKFEFKFE) having an alternating pattern of hydrophobic and 
hydrophilic amino acids was shown to form self-assembled nanofiber structures. Mechanistic 
studies showed that it formed helical ribbon initially, which transformed into fibrillar structures.30 
Molecular dynamics simulation revealed the possibility of double helical β-sheet formation. Later, 
Matsuura et al. extended the work by designing three way junctions, C3-symmetric conjugate 
trigonal (FKFEFKFE)2 consisting of three β-sheet-forming peptide FKFEFKFE (Figure 8).31 This 
peptide conjugate self-assembled into viral-sized peptide nanospheres. The above mentioned 
conjugate was soluble in acidic water but was hardly soluble in neutral and alkaline water. The 
CD spectrum of this peptide in aqueous HCl showed negative peak at 219 nm, suggesting the 
formation of β-sheet structures. Another negative peak at 200 nm was probably attributed to an 
induced CD for the benzene ring or amide bonds of the core molecule, since a CD peak was not 
observed for the component peptide FKFEFKFE alone. On the contrast, FT-IR showed bands 
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which were characteristic of antiparallel β-sheet structures. These combined results clearly indicate 
that this trigonal peptide forms hydrogen-bond-mediated intermolecular assemblies as it is not 
possible for a single trigonal (FKFE)2 molecule to form β-sheets in an antiparallel manner. The 
investigators proposed that this strategy could be widely applied to the design of spherical bio-
nanoassemblies.  
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Figure 8. Synthesis of a C3-symmetric β-sheet peptide conjugate and schematic illustration of the 
self-assembly. Reprinted with permission from ref. 31. Copyright 2013 American Chemical 
Society.  
 
Stimulus-responsive peptide self-assembly provides a powerful approach to control the 
self-assembly as a function of environment. Various stimuli-responsive systems including pH, 
ionic strength, temperature, light, and enzymes have been designed for peptide self-assembly. 
Recently, additional microenvironment-sensitive triggers for self-assembly was developed by 
Bowerman et al.32a The investigators explored the concept of reductive trigger for peptide self-
assembly. The amphipathic Ac-(FKFE)2-NH2 sequence, known to form self-assembled fibril 
nanostructures, when flanked with a cysteine (Cys) residue, Ac-C(FKFE)2CG-NH2, it formed 
macrocyclic structure via disulfide bonding and prevented the β-sheet formation that was needed 
for self-assembly. On reduction of this disulfide bond, the peptide transformed into the stable β-
sheet conformation which resulted into self-assembled fibrillar structures. At sufficient peptide 
concentration, it formed rigid hydrogels with viscoelastic properties (Figure 9).  
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Figure 9. Cyclic to linear peptide conformational switch using a reductive trigger. Reprinted with 
permission from ref. 32a. Copyright 2013 American Chemical Society.  
 
2.3. Other Peptides with β-Sheet Structures 
Traditionally, peptides are made chemically or using genetic engineering for studying the 
self-assembly process. These methods are expensive and time consuming. Moreover, it is really 
challenging to design the proper sequence to achieve the desired morphology. Jinming et al., 
demonstrated one simple method to obtain an octapeptide sequence, GAGAGAGY, from the 
natural resource, Bombyx mori silk fibroin.32b Based on this sequence, a PA, C12-GAGAGAGY 
was constructed and its self-assembly nature was investigated. It formed cylindrical nanofibers at 
pH 9 and twisted nanofibers at pH 4, indicating the involvement of electrostatic interactions in the 
self-assembly process.  
The incorporation of self-organizing peptides into synthetic polymeric materials has been 
investigated by various research groups. This kind of peptide-polymer bioconjugate is well 
documented in the literature.32c,32d It was found that alanylglycine (AG) repeating units formed 
extended β-strands in a variety of AG-rich polypeptides. On the basis of this idea, polypeptides 
containing repetitive sequence [(AG)xEG]n (x = 3-6) was made, which formed extended-plate-like 
assembled structures. When [(AG)3EG]n β-sheet polypeptides were conjugated to polyethylene 
glycol (PEG) end blocks, it prevented the macroscopic aggregation of the β-sheet blocks into 
needle-shaped lamellar crystals.33a  However, it led to the formation of  well-defined fibrils. 
Microscopy data suggested that fibril formation occurred in the β-sheet stacking direction which 
resulted in an assembly in which the hydrophobic β-sheet surfaces were screened from the polar 
solvent, whereas the PEG chains were in contact with the environment.  
26 
 
The hydrophobic-hydrophilic balance plays a key role in peptide self-
assembly/disassembly process.  To address this issue, Joris et al. demonstrated the disassembly of 
the peptide sequence Ac-KTVIIE-NH2 by manipulating hydrophobic-hydrophilic balance.
33b To 
investigate the effect of hydrophilic group in the self-assembly process, a PEG group was 
introduced on the C-terminus of the fibril forming peptide. The resulted PEG-peptide conjugate 
did not exhibit any assembled structure, presumably due to the high hydrophilicity. However, upon 
introducing the hydrophobic tail via photocleavable linker on the N-terminus fibril structure 
returned via β-sheet formation. When the hydrophobic tail cleaved on UV radiation, β-sheet 
structure was disrupted and consequently the fibrillar structure was damaged. 
Peptides adopting β-sheet secondary structures have been suggested to be useful for various 
applications, such as nanowires, fibers for biomedical purposes, scaffolds in tissue engineering, or 
to direct transport.34 However, only short fibers up to 4 µm in length are accessible. To achieve 
extended and strong nanofibers, which is stable enough to mechanical stress and eventually more 
useful in materials science, peptides with a higher tendency to form stable aggregates, are needed. 
However, the solid-phase supported synthesis (SPPS), purification, and analysis of these peptides 
is actually difficult. To address this issue, Hentschel et al studied peptide guided assembly of 
polyethylene oxide (PEO)-peptide conjugate (Figure 10).35 The peptide containing valine and 
threonine, [(Thr-Val)5], which has a high β-sheet propensity and aggregation tendency, was 
conjugated to PEO and an acid labile linker was used to liberate PEO-peptide conjugate from the 
solid support. This conjugate organized into a long, nonbranched fibers of width about 2 µm and 
lengths up to several millimeters.  
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Figure 10. Spontaneously formed aggregates by peptide guided assembly of PEO-peptide 
conjugate. Light microscopy (left) and SEM micrograph (right). Reprinted with permission from 
ref. 35. Copyright 2013 American Chemical Society.   
 
Most of the artificial β-sheet peptides are designed in such a way that the polar and 
hydrophobic amino acids are placed alternatively. This kind of arrangement promotes the 
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hydrogen bonding between amide hydrogen and carbonyl oxygen. When one side of the β-sheet 
contains hydrophobic amino acid residues, removal of hydrophobic residues from aqueous contact 
forces two β-tapes to associate into bilayered β-sheet nanoribbon (β-ribbon) structure. Recently, it 
was observed that coupling of a hydrophilic and bioactive peptide to a β-sheet forming peptide 
would enable the formation of 1D nanostructure decorated with bioactive peptides. Based on this 
idea, a supramolecular building block, Tβp was made which consisted of a cell penetrating peptide 
(CPP) Tat and a β-sheet forming peptide.36,37  
It was found that the block peptide formed a β-ribbon structure in which β-sheet interaction 
was the main driving force for the self-assembly. The Tβp β-ribbons (Figure 11) were able to 
encapsulate hydrophobic guest molecules, such as pyrene or Nile red, in the hydrophobic space 
between two β-tapes. Moreover, it was observed that cell penetration efficiency of the Tβp β-
ribbon was much higher than that of Tat-CPP only, suggesting that the multivalent coating of CPPs 
is advantageous in increasing cellular uptake efficiency.   
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Figure 11. Structure and sequence of TβP peptides. Reprinted with permission from ref. 36. 
Copyright 2013 Wiley Publishing Group. 
 
 
2.4. Vesicle/Spherical Structures 
Amphiphilic oligopeptides consisting of various ratio of hydrophilic to hydrophobic block 
length are able to self-assemble into vesicular structures in aqueous solution at neutral pH. It has 
been shown by Van-Hell et al. that hydrophilic compounds could be encapsulated within the 
peptide vesicles.18 These peptides were recombinantly produced in bacteria as an alternative to 
solid-phase synthesis. Other types of peptides that could be self-assembled to vesicles were 
copolypeptides, proline-rich peptides, and cyclic peptides.  
 
2.4.1. Copolypeptides 
Deming and coworkers reported the self-assembly behavior and application of poly(L-
lysine)-b-poly (L-leucine), poly (L-glutamic acid)-b-poly (L-leucine), and poly(L-arginine)-b-
poly (L-leucine) diblock polypeptides, where ‘b’ denotes block.38-40  Charged amphiphilic block 
copolypeptides formed stable vesicles and micelles in aqueous solution. Aqueous self-assembly of 
opposite charged poly(L-lysine)-b-poly(L-leucine) and poly(glutamic acid)-b-poly(L-leucine) 
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block copolypeptides led to the formation of unilamellar vesicles.38 The driving force for the 
aggregation of the diblock polypeptides was the α-helical hydrophobic rod formation of the 
poly(L-leucine) block. The diblock polypeptides formed vesicular structures at low hydrophobic 
residue contents (10-40 mol%). Amphiphilic diblock copolymers formed small spherical or 
cylindrical micelles in this composition range, and vesicle structures were found at higher 
hydrophobic contents (approximately 30‒60 mol%). This divergence was attributed to the rigidity 
of the chain conformation and strong interactions. The polyarginine coated vesicles showed 
potential as intracellular delivery following entrapment of hydrophilic molecules. The guanidine 
groups of arginines as crucial residues of cell penetrating peptides were responsible for the 
effective delivery of the vesicles and cargos.  
Holowka et al. used Texas Red labeled dextran, a water soluble cargo, to check the integrity 
of the vesicle membrane of poly(L-lysine)-b-poly(L-leucine). The cargo was encapsulated during 
vesicle assembly and after dialysis.39 Formed vesicles showed to contain encapsulated dextran. 
Though positively charged polypeptides were relatively unstable, whereas negatively charged 
polypeptides vesicles were quite stable. 
Rodriguez-Hernandez et al. reported pH sensitive vesicles formation for zwitterionic 
diblock copolypeptides containing poly-L-glutamic acid-b-poly-L-lysine (PGA-b-PLys).41 
Copolypeptides changed from a random coil conformation into a neutral and α-helical structure 
(rod) after neutralization of the polypeptide block (Figure 12). At acidic pH, the PGA block was 
neutralized, which produced the vesicle in the core while the PLys block formed the shell. In 
contrast, under basic conditions, the protonated PLys block was converted into neutral and 
insoluble free –NH2 groups that formed the core of the aggregates. It was assumed that the vesicle 
formation was attributed to the systematic presence of the polypeptide in a rod like morphology in 
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the hydrophobic part of the membrane, making a low interfacial twist and as a result, a hollow 
structure was formed.  
 
 
Figure 12. Schematic representation of the self-assembly into vesicles of the diblock copolymer 
PGA15-b-PLys15. Reprinted with permission from ref. 41. Copyright 2013 American Chemical 
Society. 
 
Thermally sensitive polypeptides were developed by Dreher et al.42 Temperature triggered 
self-assembly of elastin-like polypeptides (ELPs) in a linear AB diblock architecture into a 
spherical micelle was carried out through a small increase of temperature to between 37 and 42 
C. This temperature range is commonly used for clinical application of hyperthermia. The size of 
the micelle was controlled by both the length of the copolymer and hydrophilic-hydrophobic block 
ratio.  
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2.4.2. Proline-Rich Peptides 
 The self-assembly of proline-rich peptides was explored by Lee and his group.43,44 Among 
naturally occurring amino acids, proline contains a pyrrolidine ring side chain and backbone atoms. 
In the cyclic structure of proline, conformational constraints are induced among the atoms in the 
pyrrolidine ring, which results the formation of stiff helical rod structures, polyproline type II 
(PPII) helix in aqueous solution. On the other hand, biologically active and hydrophilic peptide 
coil, Tat cell-penetrating peptide (CPP) is a highly charged peptide and forms a random coil 
conformation in aqueous solution. Arginine residues in Tat CPP play the key role in the cell 
binding and entry.  
Lee and coworkers hypothesized that rigid rod character and the nonpolar nature of the 
outer surface of a PPII helix might impart microphase separation characteristics to the rod-coil of 
a PPII rod and a hydrophilic coil, leading to the anisotropic orientational ordering of the rod and 
self-assembly. Based on this idea, a block polypeptide of polyproline and an arginine oligomer, 
P10R3 was designed, and the self-assembly actions were investigated. The secondary structure of 
P10R3, consisting of 10 proline and 3 arginine residues showed characteristics of PPII helix. 
Microscopy data suggested the formation of vesicles rather than micelles (Figure 13). Another 
polypeptide P10Tat also self-assembled into vesicular structures. Both peptides P10R3 and P10Tat 
were introduced as potential carriers for delivering hydrophilic drug molecules into cells.  
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Figure 13. Structures of peptide rod–coil building blocks and their self-assembly into nanocapsule 
structures. Reprinted with permission from ref. 43. Copyright 2013 RSC Publishing Group. 
 
2.4.3. Cyclic Peptides 
Linear and cyclic peptides containing same sequence of amino acid residues showed 
differential behavior in the self-assembly process. Choi et al. reported that linear peptide 
containing tryptophan and arginine residues showed irregular morphologies whereas cyclic 
counterpart showed spherical nanostructures.44  Recently, we have performed an extensive 
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investigation on the self-assembly process of a number of cyclic peptides including [FR]4, [FK]4, 
[WK]5, [CR]4, [AK]4, and [WR]4 containing L-amino acids (Figure 14).
45 
 
Figure 14. Chemical structures of synthesized cyclic peptides (F = phenylalanine, R = 
arginine, K = lysine, W = tryptophan, C = cysteine, A = alanine). Reprinted with permission from 
ref. 45.  
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The rationale behind the selection of amino acids in the structure of the peptide was based 
on the presence of alternating hydrophobic and positively charged residues or alternating neutral 
and positively charged residues in their structures. We hypothesized that the self-assembled 
nanostructures in aqueous solution could be formed through intramolecular and/or intermolecular 
interactions through an optimal balance of hydrophobicity and charge. Among all the designed 
peptides, one of the peptides, namely [WR]4, generated self-assembled nanostructures at room 
temperature after a specific incubation time. The presence of the tryptophan’s indole ring of in 
[WR]4 was found to play a critical role in self-assembly process due to its high hydrophobicity 
through generating potential hydrophobic interactions. Furthermore, the presence of the positively 
charged guanidine group in the arginine was found to be involved in hydrogen bonding 
interactions. However, other 5 cyclic peptides did not show self-assembled nanostructures possibly 
due to inappropriate combination of hydrophobic and positively charged residues. As a result of 
the unique behavior of [WR]4, and to investigate the role of the ring size, other derivatives in this 
group [WR]3 and [WR]5, were designed and tested to determine the effect of the ring size on the 
self-assembly process. TEM was used to investigate the morphologies of [WR]3 and [WR]5. All 
compounds in this class showed vesicle-type structures. TEM of [WR]3 showed that this peptide 
forms structure within sizes of 100 nm after 14 days of incubation. [WR]4 and [WR]5 were 
observed in larger structures (550 and 930 nm, respectively) (Figure 15). The results indicated that 
three major elements are involved in the self-assembly process of these cyclic peptides including 
hydrophobic force, hydrogen bonding by partial β-structures, and/or the π- π stacking interactions 
between tryptophan residues.45 
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Figure 15. (a) and (b) FE-SEM image of self-assembled structure of [WR]5 (2 mM) in water after 
20 days; (c) TEM images of self-assembled structures of [WR]3 in water after 2 weeks (without 
negative staining); (d) TEM images of self-assembled structures of [WR]4 in water after 2 weeks 
(without negative staining); (e) TEM images of self-assembled structures of [WR]5 in water after 
2 weeks (without negative staining). Reprinted with permission from ref. 45.  
 
We further investigated the new applications of this class of cyclic peptides for generating 
cyclic peptide capped gold nanoparticles (CP-AuNPs) as potential drug delivery purposes.46 We 
37 
 
found out that the combination of tryptophan and positively charged amino acids worked as 
reducing/capping agents and led to the formation of in-situ functionalized metal nanoparticles. 
Moreover, we noticed that the cyclic peptides containing alternative tryptophan and lysine 
(c[WK]5) produce different gold nanoparticles when compared with their linear counterpart 
(l(WK)5).
47 TEM investigations showed that l(KW)5-AuNPs formed ball-shaped structures with 
the diameter size of 900−1000 nm (Figure 16). A large number of l(KW)5-AuNPs were found to 
be in spherical morphologies and in the size range of 4−35 nm. The distribution pattern of AuNPs 
in of l(KW)5-AuNPs was found to be an organized arrangement. 
  
Figure 16. TEM images of l(KW)5-AuNPs. Reprinted with permission from ref. 47. Copyright 
2013 American Chemical Society.  
 
Compared to linear peptide-capped AuNPs, TEM images of c[KW]5-AuNPs showed 
sponge-like agglomerates. The spongy agglomerates were composed of peptide and AuNPs with 
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an approximate diameter size of 250−450 nm (Figure 17) along with some isolated AuNPs in 
spherical and triangular shapes (6−60 nm).  
 
Figure 17. TEM images of c[KW]5-AuNPs. Reprinted with permission from ref. 47. Copyright 
2013 American Chemical Society.  
 
These data suggested that the constrained nature of the peptide in c[KW]5-AuNPs caused 
different orientation of amino acids in the secondary structure of peptide causing the formation of 
different environment surrounding the complex that led to the formation of organized 
morphologies by the peptides. This orientation altered the number of available amino acids such 
as tryptophan and/or lysine residues in reduction process of the Au3+. However, l(KW)5 more 
flexibility in the conformation compared to the corresponding constrained cyclic counterpart 
c[KW]5 during the AuNPs formation. Additional positively charged amino groups and negatively 
charge carboxylates at N-terminal lysine and C-terminal tryptophan, respectively, could also 
participate in self-assembly process through intermolecular interactions of the peptide. Thus, the 
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cyclic and linear nature of the peptide and the orientation of amino acids were found to be the main 
reason for the different morphology and size of formed P-AuNPs. 
Furthermore, the assemblies between a cyclic peptide ([WR]4) as a drug delivery system 
and molecular cargos were investigated.48 A negatively charged phosphopeptides (PEpYLGLD) 
was selected as a model cargo molecule. TEM investigation of negatively stained [WR]4 alone 
showed circular vesicle-like structures with approximate size of 25−60 nm. TEM images of 
PEpYLGLD (Figure 18) exhibited mostly amorphous structures with approximate size of 40 nm. 
However, when PEpYLGLD was mixed with [WR]4 in solution, PEpYLGLD-loaded [WR]4 
formed some larger noncircular morphologies with width and height of 125 and 60 nm, 
respectively. 
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Figure 18. Negatively stained TEM images of [WR]4 (1 mM), PEpYLGLD (1 mM), and 
PEpYLGLD-loaded [WR]4 (1 mM) in water after one day. Reprinted with permission from ref. 
48. Copyright 2013 American Chemical Society.   
 
We proposed that the available electrostatic and/or hydrophobic intermolecular 
interactions between the positively charged cyclic peptide and negatively charged 
phosphopeptides was responsible for the self-assembly process (Figure 19). The structure of [WR]4 
was investigated by using TEM microscopy showing modified morphologies upon binding with 
PEpYLGLD by generating new nanostructures. 
 
Figure 19. Proposed mechanism of the self-assembly and interactions between PEpYLGLD and 
[WR]4. Reprinted with permission from ref. 48. Copyright 2013 American Chemical Society. 
  
In conclusion, our efforts were focused on developing new sequences of amino acids in the 
structure of cyclic peptide for biomedical applications.49,50 Our findings showed that the cyclic 
nature of the peptide was a critical element in the self-assembly process and their biological 
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activity possibly because of the constrained structure and different orientation of amino acids in 
their secondary structure.  
 
2.5. Amyloid Nanofibrils 
The self-assembly of peptides and proteins into fibrillar structure formation is very 
common phenomena in biological systems. Amyloid fibrils are key examples of protein self-
assembly into nano-fibrillar structures.51 The accumulation of amyloid fibrils is a common 
characteristic of various diseases including Alzheimer’s disease, type II diabetes, Parkinson’s 
diseases, and many others.52 Furthermore, self-assembled nanofibrils generated from natural or 
artificial peptides have been suggested for potential application in bionanotechnology. Amyloid 
fibrils have β-sheet conformation generated by polypeptides of 30-40 amino acids or longer. It has 
been shown that short peptide fragments, for example, tetra- to hexapeptides, form fibrillar 
structure with similar biophysical and structural properties of amyloid fibrils.53 Thus, they can be 
used as a model system for studying amyloid fibrils formation and biological self-assembly 
processes. NFGAIL and FGAIL are very good examples of short peptides, which can self-
assemble into fibrillar structure.54 
 To understand the amyloid fibril formation better, further investigations were conducted to 
find the minimum peptide fragment which was responsible for amyloid fibrils formation. It was 
found that aromatic residues played critical roles in the process of amyloid formation. 
Diphenylalanine (FF) is the core recognition motif of the Alzheimer’s β-amyloid polypeptide. FF 
leads the process of self-assembly in the molecule. In fact, dipeptide containing FF underwent self-
assembly into nanotubes through a combination of π-π stacking and hydrogen bonding (Figure 
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20).55 Larger peptides and conjugated organic molecules that contain this motif inhibited fibrils 
formation by Aβ.56,57 
 
Figure 20. The formation of amyloid fibrils. Folded monomer undergoes a conformational 
transition into a b-sheet-rich state, usually through a partial unfolded state. Self-assembly of these 
intermediates into ladders of b strands results in the formation of ordered filaments that aggregate 
into the well-known amyloid fibrils. Reprinted with permission from ref. 55. Copyright 2013 
Wiley Publishing Group.  
 
These peptide nanotubes developed from diphenylalanine are significantly rigid and 
potentially useful in electrochemical biosensing.58 Gazit et al. and Ulijn et al. found that 9-
fluorenylmethoxycarbonyl (Fmoc) protected diphenyalanine (Fmoc-FF) self-assembled into 
nanofibrils in aqueous solution, which led to a hydrogel formation.55-60 The rheological pattern of 
this hydrogel exhibited similarity to solid-like gels materials. This hydrogel was significantly 
stable at a wide range of temperatures and pH values including extreme acidic conditions. Recent 
molecular modeling studies showed that, peptides in this gel were aligned in an antiparallel β-sheet 
fashion and adjacent sheet like interlocked through lateral π-π interactions, which resulted to the 
formation of a cylindrical structure.61 Modification of this dipeptide by N-terminal acetylation and 
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amidation of the C-terminal carboxyl led to the formation of nanotube structures of similar 
properties. These data indicated the key role of aromatic moieties in the generation of peptide 
nanotubes.62 
Further extension of this study by Gazit et al. showed that diphenylglycine, a similar 
analogue of diphenylalanine and the simplest aromatic peptide, formed nanospheres. These 
nanostructures were stable under extreme chemical conditions. The introduction of a thiol group 
by incorporation of a cysteine residue into FF peptide modified the self-assembly properties of the 
resultant building blocks. Cysteine-diphenylalanine tripeptide self-assembled into spherical 
vesicles instead of nanotubes.7 
 
2.6. Rod-Coil/Coiled coil Nanostructures 
Rod-coil nanostructures have a chain of rod-like stiffness and flexible coil-like block. Like 
other supramolecular building blocks, rod-coil block molecules can be used to construct a variety 
of distinct nanostructures of controlled size and shape in some selective solvents. For aqueous self-
assembly of this molecule, one part was designed to be hydrophilic, and another part was 
hydrophobic. For example, Holowka, et. al. reported the preparation of charged amphiphilic block 
copolypeptides that formed vesicles and micelles in water. They were synthesized a class of 
poly(L-lysine)-b-poly(l-leucine) block copolypeptides, KxLy, where X = 20‒80 and y =  10-30 amino 
acids (Figure 21).63 
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Figure 21. Schematic drawing showing proposed self-assembly of K60L20 into vesicles. Reprinted 
from ref. 63. Copyright 2013 American Chemical Society.   
 
Lomander et al reported the hierarchical self-assembly of a coiled-coil peptide of 31 
residues containing charged and hydrophobic residues.64 The sequence is 
WGCIKQLEDKIEELLSKIY-HLENEIARLKKL. Internal cysteine has been used in the sequence 
to generate disulfide covalent bond between two separate peptide coiled-coils. Even though coiled-
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coil peptide contained many charges, the secondary structure of the peptide in all pH ranges 
showed a typical α-helix with some variation of helical content. These findings suggested that the 
neutralization of the charged residues did not completely disrupt the secondary structure of the 
coiled-coil, mainly due to the hydrophobic interactions of two helices.  
Coiled-coil peptides were reported to be an effective scaffold for creating new 
nanostructures. One such example is demonstrated by Ryadnov et al.65 who designed a nanoreactor 
with multiple cavities by using self-assembled supramolecular dendrimers, which were termed as 
supradendrimers (SD) in two steps. The first step was the self-assembly of a single peptide 
sequence SD-1 (QEIARLEQEIARLEYEIARLE), which was based on a dimeric coiled coil also 
known as the leucine zipper. In folding state, SD-1 dimers were rigid rods. However, when self-
assembly started and was sustained by the formation of hollow dendrimer cells, the rods extended 
into tightly packed noncovalent networks. TEM revealed very dense mesoscopic assemblies of a 
hexagonal paracrystalline phase, which proposed with the formation of a hierarchically ordered 
architecture of SD-1 supradendrimers.  
Second step was to generate cavities in the dendrimer cells. To accomplish this, another 
complementary sequence SD-2 [Ac-(K(KIEALKOKIEALKYKIEALK- ɛAhx))3 – am] where 
ɛAhx was ɛ-aminohexanoic acid, was assembled with SD-1, resulting a dimer SD-1,2 (Figure 22). 
Furthermore, to demonstrate the encapsulation ability of this dimer, a redox reaction was carried 
out, where boiling solution of silver nitrate was added into the dimer followed by the addition of 
sodium citrate as a reductant. This reaction led to the formation of silver nanoparticles having the 
size of the cavities, indicating nanoreactor nature of the dimer.  
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Figure 22. Schematic representation of the supradendrimer design. SD-1 (1) and SD-2 (2) peptide 
sequences are shown with the one-letter code and are simplified into helical wheels with 3.5 
residues per turn. The sequences show heptad repeats characteristic of canonical coiled coils, 
commonly labeled a–g. Residues at sites a and d shape helix–helix interfaces. These are 
hydrophobic and made up of isoleucine and leucine, respectively, to ensure the formation of 
dimers. A) SD-1-type of electrostatic interactions, g–c–e’: e’ and g positions are occupied by 
glutamates that form salt bridges with arginine residues at c; g–c interactions are intrahelical, 
whereas c–e’ are interhelical and are between two SD-1 copies of different dimers. Dimers 
trimerize (I) to give a noncovalent dendrimeric architecture, with a branching cell formed by six 
dimers (II). A single cysteine residue in the f position that replaces a glutamine is shown in 
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brackets. B) Mixed SD-1/SD-2 (SD-1,2)-type of electrostatic interactions, g–c–e’(1)/b–e, g–e’(2): 
intrahelical b–e interactions in 2 inhibit interhelical e–g’ interactions; g–e’ interactions contribute 
to the 1–2 interface. Because the width of a superhelix is approximately 2 nm, the diameter of an 
extended branching cell (II’) is estimated to not exceed 4–6 nm. To form the supradendrimer II’, 
each copy of SD-2 should be arranged with at least nine copies of SD-1 to round the equimolar 
SD-1,2 ratio to 10:1. SD-2 wheels are highlighted in black around an ac-KKK-am hub containing 
an e-aminohexanoic acid (eAhx) as spacer. The circles of helical wheels are black for arginines, 
gray for glutamates, and outlined in gray for lysines. Arrows represent salt bridges. Reprinted with 
permission from ref. 65. Copyright 2013 Wiley Publishing Group.   
 
 
 
 
 
 
 
 
 
 
48 
 
 
Table 1. Summary of peptides sequences and their self-assembled nanostructures incorporated in 
this review. 
Peptide Sequence Nanostructure Reference 
L-Phe-L-Phe ( FF) Nanotubes 8 
cyclo[(D-Ala-Glu-D-Ala-Gln)2] Nanotubes 9 
NH2-(D)Naph-Cys-Tyr-(D)Trp-Lys-Val-
Cys-Thr-CONH2 
Nanotubes 12 
GnD2–OH (where n= 4, 6, 8, 10) Nanotubes 14 
Ac-V6D-OH Nanotubes and nanovesicles 15a 
I3K (Ac-I3K-NH2) Nanotubes 15a 
Ac-GAVILRR-NH2 Nanosphere and nano-doughnut 16 
Ac-A2V2L3WE2/7–OH Nano-vesicles 18 
A6K Nanotubes or nanofibrils 19 
A9K Nanorods 20a 
DiC16-EQLESIINFEKLTWE cylindrical micelles 20b 
IKVAV nanofiber 22 
A12R2 twisted fibril 27b 
Fmoc-βAH Nanofibril 27c 
C16-βAH Nanotape 27d 
C16-KTTKS Fibrillar 27e 
C16-KTTKS and C16-ETTES (mixed) Nanotape 27h 
C16-W3K (1 day) Spherical micelles 27i 
C16-W3K (13 days) Worm-like micelles 27i 
Polyethylene glycol- DGRFFF Nanofibril 27l 
Lauryl-VVAGE-Dopa-Am and Lauryl-
KRSR-Am (KRSR-PA) (Mixture) 
Nanofiber 27m 
Palmitoyl-GV3A3E3 Fibril 28 
VEVE Nanobelt 26,29 
VVEE Cylindrical nanofibers 26 
FKFEFKFE Nanofiber 30 
C3-symmetric peptide conjugate trigonal 
(FKFEFKFE)2 
Nanospheres 31 
Ac-(FKFE)2-NH2 Amyloid fibril 32a 
C12-GAGAGAGY Nanofiber 32b 
Polyethylene glycol-[(AG)3EG]n  Fibril 33a 
Polyethylene oxide-[(Thr-Val)5] Fibers 35 
R-GRKKRRQRRRPPQGSGG-
FKFEFKFEFKFE 
Nanoribbon 36 
Poly(L-lysine)-b-poly(L-leucine) and 
Poly(glutamic acid)-b-poly(L-leucine) 
Vesicles 38 
PGA-b-PLys Vesicles 41 
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P10R3, P10Tat Vesicles 43,44 
[WR]n (n=3-5) Vesicle-like 45 
l(KW)5-AuNPs Ball-shaped structures 47 
c[KW]5-AuNPs Sponge-like agglomerates 47 
PEpYLGLD-loaded [WR]4 Large noncircular morphologies 48 
Fmoc-FF Nanofibrils 60 
Diphenylglycine Nanotubes and nanospheres 8 
Cysteine-diphenylalanine tripeptide Spherical vesicles 7 
Poly(L-lysine)-b-poly(l-leucine)  Vesicles and micelles 63 
WGCIKQLEDKIEELLSKIY-
HLENEIARLKKL 
Coiled coils 64 
SD-1 (QEIARLEQEIARLEYEIARLE) Coiled coils 65 
 
3. Conclusions and Future outlook  
Peptides are highly versatile structural building blocks and can generate supramolecular 
architectures, including sheets, spheres, fibres, tapes, and tubes. Self-assembled peptides are able 
to form numerous nanostructures through various types of interactions, such as electrostatic, 
hydrophobic, and hydrogen bonding. They can take advantage of diversity in the body of amino 
acid residues including positive or negative charge along with hydrophobic or hydrophilic 
properties. More studies are required in rational peptide design to investigate systematically the 
role of hydrophobicity, electrostatics, and size on pattern formation and to examine sequence 
effects on morphologies, and elucidate the fundamental physical interactions that drive their self-
assembly. These investigations will assist us to determine the guiding principles in terms of roles 
of size, charge, and hydrophobicity for self-assembly into specific structures.  
Several challenges including size control, undesired aggregation, pH stability and chemical 
and enzymatic stability need to overcome in design and functionalizing peptide nanostructures. 
The use of peptide nanostructures as drug delivery vehicles, imaging contrast agents and/or 
biosensors requires a good stability in the solution in question (e.g., buffer). For instance, Stupp and 
his group found that some PAs were unstable upon pH change.24 When a dumbbell-shaped 
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hydrophobic core was added into the sequence, it showed enhanced stability.25  However,  
extensive studies are required to evaluate  the properties of peptide nanostructures upon the pH 
change. It was found that tryptophan containing cyclic peptides [WR]n (where n = 3-5) did not 
exhibit self-assembled nanostructures immediately, but in a long period of time (approximately 12 
days).45 This issue can be addressed by altering the hydrophobic–hydrophilic ratio in the peptide 
sequence. The control of the size of peptide nanostructures is very crucial in its applications such 
drug delivery systems and biosensors. Nanostructures of equivalent dimension are needed for the 
fabrication of biosensing platforms of similar characteristics. It is very challenging to control the size 
of the nanostructures during the synthesis due to the self-assembly process. To obtain the 
nanostructures of similar dimension, change in fabrication parameters or use of templates can be 
beneficial.  The size distribution of self-assembled peptides can be controlled with external stimulus, 
such as pH, ionic strength, solvent, chemical additives, or temperature. Particle size, charge, and size 
distribution can be intelligently engineered to affect the stability of self-assembled structure and 
encapsulation properties. Because of the presence of hydrophobic groups in some peptides, 
aggregation could occur. An optimal balance of hydrophobicity and charge could generate self-
assembled nanostructures in aqueous solution by intramolecular and/or intermolecular interactions 
minimizing aggregation through hydrophobic groups. In some cases, due to strong interactions some 
crude peptides aggregate and thus, difficult to purify. Effective synthetic strategies are needed to 
overcome this problem.  
Second, self-assembled peptides have been studied in diverse applications ranging from 
imaging, biomineralization, tissue engineering, and drug delivery, due to their inherent 
biocompatibility and biodegradability. Designing self-assembled peptides has emerged as an 
effective tool in applications ranging from energy storage, tissue engineering, drug and gene 
51 
 
delivery, membrane protein stabilization, due to their inherent biocompatibility and 
biodegradability. A deep understanding of self-assembly by amphiphilic peptides through 
systematic design and study of unexplored peptide sequences is urgently required to develop the 
next generation of self-assembled peptides for various applications, such as encapsulating 
hydrophobic compounds. Based on the desired applications, different number and types of amino 
acids can be used. Moreover, they can be easily conjugated with antibodies, enzymes, quantum 
dots, and metal nanoparticles to enhance their stabilization and biocompatibility. Peptide 
nanomaterials as self-assembled structures continue to have potential applications as encapsulation 
and/or drug delivery tools. Although further investigations on self-assembled peptide 
nanoparticles are required, they have already been used for different applications including drug 
delivery, wound healing, tissue engineering, surfactants, and tissue repair. It is envisioned that the 
peptide nanostructures may be specifically used in tissue engineering (e.g., wound healing and 
nerve regeneration), drug delivery, imaging, and active targeting to disease-relevant cell types for 
the efficacious treatment of a variety of ailments, including cancer and neurodegenerative 
disorders. Nevertheless, the application of peptide nanostructures in the area of 
gene/oligonucleotide delivery has not been explored extensively. The intracellular delivery of such 
macromolecules in their active form remains a challenging task. To address this issue, rationally 
designed peptide-polymer conjugates with desired properties are needed to explore. Furthermore, 
the biocompatibility and immunogenicity of the self-assembled peptide biomaterials is needed to 
study completely for possible biomedical applications. The synthesis of a variety of self-assembled 
peptides has been previously reported, but a predictive understanding for rational design of peptide 
self-assembly is still lacking. Thus, there is an urgent need to study systematically alternative 
peptides for establishing the relationship between the morphology of self-assembled peptides with 
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their physicochemical properties (e.g., sequence, size, charge, and 3D structure of the monomer). 
There is also a need to further study alternative systems for the prediction of structure of self-
assembled peptides based on their sequence and other physiochemical properties. 
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